Thursday, November 29, 2012 4:38:28 PM
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On 14 November 2012, Amarantus Biosciences, Inc. (the "Company") filed a Certificate of Amendment to its Certificate of Incorporation, as amended, effecting an increase in the total number of authorized common shares of the Company from 250,000,000 to 1,000,000,000.
The 14 January 2012 Amendment to the Certificate of Incorporation is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
Substantial dilution is on the way. $3,000,000 in losses in nine months with only three employees. This is headed to .005. IMHO.
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM